Entero Healthcare Solutions Ratios

Entero Healthcare Solutions Ltd Ratios

The Entero Healthcare Solutions Ltd Ratios page provides a complete fundamental analysis of Entero Healthcare Solutions Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Entero Healthcare Solutions Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Entero Healthcare Solutions Ltd (NSE: ENTERO, BSE: 544122) is currently trading at ₹1581.10, with a market capitalization of ₹6928.44Cr. As a major player in the Distribution services sector and Medical distributors industry, Entero Healthcare Solutions Ltd remains a key stock for fundamental analysis using Entero Healthcare Solutions Ltd Ratios.

Entero Healthcare Solutions Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Entero Healthcare Solutions Ltd P/E ratio currently stands at 52.22, making it one of the most tracked metrics in Entero Healthcare Solutions Ltd Ratios.

Historically, the Entero Healthcare Solutions Ltd P/E ratio has shown strong fluctuations:

• 2025: 52.22
• 2024: 91.09
• 2023: 0
• 2022: 0
• 2021: 0

The decline in Entero Healthcare Solutions Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Entero Healthcare Solutions Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 2.87.

Historical P/B trend:

• 2025: 2.87
• 2024: 2.62
• 2023: 0
• 2022: 0

Entero Healthcare Solutions Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Entero Healthcare Solutions Ltd P/S ratio currently stands at 0.97, an important part of Entero Healthcare Solutions Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2025: 0.97
• 2024: 0.91
• 2023: 0
• 2022: 0

The rising Entero Healthcare Solutions Ltd P/S ratio indicates improved revenue valuation by investors.

Entero Healthcare Solutions Ltd Price to Cash Flow Ratio (P/CF)

The Entero Healthcare Solutions Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Entero Healthcare Solutions Ltd Price to Cash Flow Ratio:

• 2025: 0
• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

The declining Entero Healthcare Solutions Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Entero Healthcare Solutions Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Entero Healthcare Solutions Ltd EV currently stands at ₹4921Cr, representing the total company valuation including debt.

Historical EV trend:

• 2025: 4921Cr
• 2024: 3011Cr
• 2023: 0
• 2022: 0

Entero Healthcare Solutions Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Entero Healthcare Solutions Ltd EV/EBITDA ratio is currently 28.59, a key metric in Entero Healthcare Solutions Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2025: 28.59
• 2024: 26.92
• 2023: 0
• 2022: 0

Higher Entero Healthcare Solutions Ltd EV/EBITDA suggests premium valuation.

Entero Healthcare Solutions Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Entero Healthcare Solutions Ltd D/E ratio is currently 0.22, reflecting leverage and financial stability.

Historical D/E:

• 2025: 0.22
• 2024: 0.21
• 2023: 0.74
• 2022: 0.63

Entero Healthcare Solutions Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Entero Healthcare Solutions Ltd ROE currently stands at 5.64%, showing profitability and capital efficiency.

Historical ROE:

• 2025: 5.64
• 2024: 3.50
• 2023: -2
• 2022: -5.72

Declining ROE indicates pressure on profitability.

Entero Healthcare Solutions Ltd Ratios Analysis Summary

The Entero Healthcare Solutions Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Entero Healthcare Solutions Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Entero Healthcare Solutions Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.